Raising prospects for a continued deterioration in the stock price of Ligand Pharmaceuticals Inc. (NASDAQ:LGND), the largest shareholder in the company has moved to unload shares of the troubled company in a private transactions. …
12:24a $TWTR survived all bad quarters and finally with 1 good quarter races to $3.. 02/09 $GBDC Stock Quote Alert for Golub Capital BDC Inc. (NASDAQ:GBDC) From our Sto.. 02/09 $TROV Stock Quote Alert for TrovaGene Inc. …
That creates more demand for the stock, which pushes it higher, which forces more shorts to buy the shares and so on and so on. Look at Ligand Pharmaceuticals Inc. (NASDAQ:LGND). The stock has had a big run this year, especially …
Ligand Pharmaceuticals Incorporated LGND is scheduled to report second-quarter 2016 results on Aug 4 before the market opens. In the last reported quarter, Ligand had posted a positive earnings surprise of 67.39%. Let’s see how things are …
For a hedged play on Ligand Pharmaceuticals (LGND), MarketIntelligenceCenter.com’s option-trade picking algorithms recommend the Mar 16, 2018 $155 covered call for a net debit in the $151.69 area. That is also the break-even stock
Ligand Pharmaceuticals Inc. LGND is scheduled to report third-quarter 2017 results ... Quote Ligand’s shares have outperformed the industry so far this year. The stock has rallied 44.1% compared with the industry’s 3.9% increase. …
Ligand Pharmaceuticals Inc. LGND reported third-quarter 2017 adjusted earnings of ... Ligand’s shares have outperformed the industry year to date. The stock has soared 42.5% compared with the industry’s 2.7% increase. View photos Total …
Yahoo!3mon
Ligand Pharmaceuticals Inc. (LGND) reported second quarter EPS of $0.67 after the bell Monday, up from $0.35 in the prior year period. Ligand Pharmaceuticals gapped open higher Tuesday and spiked to the upside in early trade. The …
Cloud Computing Magazine Click here to read latest issue Subscribe for FREE - Click Here IoT EVOLUTION …